Table 1.

Baseline characteristics of the study groups.

		Group 1 No stones	Group 2 stones	Test value	P–value
		n = 55	n = 28
Age	Mean ± SD	49.13 ± 7.94	49.21 ± 9.54	−0.044≠≠	0.965
	Range	19–62	30–65
Sex	Female	4 (7.3%)	3 (10.7%)	0.285•	0.594
	Male	51 (92.7%)	25 (89.3%)
BMI	Mean ± SD	27.88 ± 5.13	28.43 ± 3.00	−0.525≠≠	0.601
	Range	17–40	22–36
CHILD score	Median (IQR)	10 (9–11)	10 (9–11)	−0.024≠	0.980
	Range	5–13	8–13
MELD score	Median (IQR)	17 (14–19)	16.5 (14.5–19)	−0.672≠	0.502
	Range	8–25	11–24
Etiology	HCV	26 (47.3%)	20 (71.4%)	4.382•	0.036*
	HCV/HCC	20 (36.4%)	6 (21.4%)	1.924•	0.165
	HBV	1 (1.8%)	0 (0.0%)	0.515•	0.473
	AIH	2 (3.6%)	0 (0.0%)	1.043•	0.307
	Cryptogenic	4 (7.3%)	1 (3.6%)	0.449•	0.503
	Cryptogenic/HCC	2 (3.6%)	0 (0.0%)	1.043•	0.307
	PBC	0 (0.0%)	1 (3.6%)	1.988•	0.159
DM	Negative	41 (74.5%)	25 (89.3%)	2.475•	0.116
	Positive	14 (25.5%)	3 (10.7%)
HTN	Negative	52 (94.5%)	26 (92.9%)	0.093•	0.760
	Positive	3 (5.5%)	2 (7.1%)
Pre–transplant gall bladder stone	Negative	45 (81.8%)	21 (75.0%)	0.530•	0.467
	Positive	10 (18.2%)	7 (25.0%)

SD, standard deviation; IQR: interquartile range; BMI, body mass index; CHILD, the Child–Pugh score; MELD, Model for End–Stage Liver Disease score; HCV, hepatitis C virus; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; PBC, primary biliary cholangitis; AIH, autoimmune hepatitis; DM, diabetes mellitus; HTN: hypertension.

^•Chi–Square test;

^≠Mann–Whitney test;

^≠≠Independent T–test.

^*Significant at p < 0.05.